Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effects of Different Doses of Aspirin on Pathophysiological Markers in Type 2 Diabetes

This study has been completed.
Sponsor:
Information provided by:
University of Portsmouth
ClinicalTrials.gov Identifier:
NCT00898950
First received: May 11, 2009
Last updated: NA
Last verified: May 2009
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2006
  Primary Completion Date: July 2006 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):